Strategies in Stable Chronic Coronary Disease

  • David Corcoran
  • Damien Collison
  • Tom Ford
  • Colin BerryEmail author


Stable coronary artery syndromes include patients with angina caused by obstructive coronary artery disease, by a disorder of coronary vascular function, or by a combination of these two clinical entities. The diagnostic pathway in patients presenting with chest pain and suspected stable coronary artery disease (SCAD) can be challenging because of variations in the pre-test probability of CAD and in the accuracy and local availability of diagnostic tests. There is uncertainty regarding the comparative effectiveness of non-invasive imaging-based diagnostic strategies for the detection of CAD and their role in directing ongoing management. In this chapter, we review the evidence base and clinical practice guideline recommendations underpinning non-invasive and invasive diagnostic strategies.

Optimal medical therapy (OMT) forms the cornerstone of treatment of SCAD. Nevertheless, myocardial revascularisation reduces ischaemia and improves symptoms to a greater extent than OMT alone. In contrast to revascularisation in the context of acute coronary syndromes, randomised controlled trials of revascularisation in SCAD have not demonstrated a mortality benefit. Revascularization decisions must take into account the totality of clinical data, namely, the coronary anatomy, patient-specific clinical factors such as age and co-morbidity, and the feasibility of complete revascularisation. We discuss the key evidence and clinical practice guideline recommendations for myocardial revascularisation of patients with SCAD.

Finally, we describe the conundrum of patients presenting with angina and no obstructive CAD. We discuss the requirement for a comprehensive invasive assessment of coronary physiology in these patients to clarify the diagnosis and to direct ongoing care.


Stable coronary artery disease Angina Optimal medical therapy Revascularisation PCI CABG Ischaemia Microvascular 


  1. 1.
    Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRefGoogle Scholar
  2. 2.
    Kolh P, Windecker S. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J. 2014;35(46):3235–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, preventive cardiovascular nurses association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60(24):e44–e164.CrossRefPubMedGoogle Scholar
  4. 4.
    Valdiviezo C, Motivala AA, Hachamovitch R, Chamarthy M, Navarro PC, Ostfeld RJ, et al. The significance of transient ischemic dilation in the setting of otherwise normal SPECT radionuclide myocardial perfusion images. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2011;18(2):220–9.CrossRefGoogle Scholar
  5. 5.
    Shah R, Yow E, Jones WS, Kohl LP 3rd, Kosinski AS, Hoffmann U, et al. Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: findings from the prospective multicenter imaging study for evaluation of chest pain (PROMISE) trial. Am Heart J. 2016;184:1–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Park SJ, Kang SJ, Ahn JM, Shim EB, Kim YT, Yun SC, et al. Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv. 2012;5(10):1029–36.CrossRefPubMedGoogle Scholar
  7. 7.
    Curzen N, Rana O, Nicholas Z, Golledge P, Zaman A, Oldroyd K, et al. Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?: the RIPCORD study. Circ Cardiovasc Interv. 2014;7(2):248–55.CrossRefPubMedGoogle Scholar
  8. 8.
    Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, et al. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry. Circulation. 2014;129(2):173–85.CrossRefPubMedGoogle Scholar
  9. 9.
    Curzen N. RIPCORD 2 slide, FFR in the diagnostic phase. Lecture, ETP coronary physiology in the catheterization laboratory course, European Society of Cardiology. 2015.Google Scholar
  10. 10.
    Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301(2):61–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Johnson NP, Jeremias A, Zimmermann FM, Adjedj J, Witt N, Hennigan B, et al. Continuum of vasodilator stress from rest to contrast medium to adenosine hyperemia for fractional flow reserve assessment. JACC Cardiovasc Interv. 2016;9(8):757–67.CrossRefPubMedGoogle Scholar
  12. 12.
    Greenwood JP, Ripley DP, Berry C, McCann GP, Plein S, Bucciarelli-Ducci C, et al. Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion Scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA. 2016;316:1051.CrossRefPubMedGoogle Scholar
  13. 13.
    National Institute for Health Care and Excellence (NICE). Chest pain of recent onset: assessment and diagnosis. 2010. Available from:
  14. 14.
    Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300(24):1350–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Pickett CA, Hulten EA, Goyal M, Surry L, Villines TC. Accuracy of traditional age, gender and symptom based pre-test estimation of angiographically significant coronary artery disease in patients referred for coronary computed tomographic angiography. Am J Cardiol. 2013;112(2):208–11.CrossRefPubMedGoogle Scholar
  16. 16.
    SCOT-HEART Investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015;385(9985):2383–91.CrossRefGoogle Scholar
  17. 17.
    Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103(24):2928–34.CrossRefPubMedGoogle Scholar
  18. 18.
    Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213–24.CrossRefPubMedGoogle Scholar
  19. 19.
    De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991–1001.CrossRefPubMedGoogle Scholar
  20. 20.
    Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.CrossRefPubMedGoogle Scholar
  21. 21.
    BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503–15.CrossRefGoogle Scholar
  22. 22.
    Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–84.CrossRefPubMedGoogle Scholar
  23. 23.
    Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.CrossRefPubMedGoogle Scholar
  24. 24.
    Head SJ, Kaul S, Mack MJ, Serruys PW, Taggart DP, Holmes DR Jr, et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease. Eur Heart J. 2013;34(32):2510–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention J EuroPCR Collab Work Group Interv Cardiol Eur Soc Cardiol. 2005;1(2):219–27.Google Scholar
  26. 26.
    Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003;24(9):881–2.CrossRefPubMedGoogle Scholar
  27. 27.
    Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44. discussion 44-5.CrossRefPubMedGoogle Scholar
  28. 28.
    Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2–22.CrossRefPubMedGoogle Scholar
  29. 29.
    CASS Principal Investigators and Their Associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med. 1984;310(12):750–8.CrossRefGoogle Scholar
  30. 30.
    Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43(10):1743–51.CrossRefPubMedGoogle Scholar
  31. 31.
    Windecker S, Stortecky S, Stefanini GG, da Costa BR, Rutjes AW, Di Nisio M, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014;348:g3859.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Nam CW, Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011;58(12):1211–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Zimmermann FM, De Bruyne B, Pijls NH, Desai M, Oldroyd KG, Park SJ, et al. Rationale and design of the fractional flow reserve versus angiography for multivessel evaluation (FAME) 3 trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015;170(4):619–26. e2.CrossRefPubMedGoogle Scholar
  34. 34.
    Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36(45):3182–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (fractional flow reserve versus angiography for multivessel evaluation) study. J Am Coll Cardiol. 2010;56(3):177–84.CrossRefPubMedGoogle Scholar
  36. 36.
    van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, Engstrom T, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. 2015;386(10006):1853–60.CrossRefPubMedGoogle Scholar
  37. 37.
    De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(13):1208–17.CrossRefPubMedGoogle Scholar
  38. 38.
    Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629–38.CrossRefPubMedGoogle Scholar
  39. 39.
    Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol. 1995;26(7):1600–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375(23):2223–35.CrossRefPubMedGoogle Scholar
  41. 41.
    Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016;388(10061):2743–52.CrossRefPubMedGoogle Scholar
  42. 42.
    Capodanno D, Bass TA. Revascularization of unprotected left main coronary artery disease: implications of evolving data on clinical practice. Circ Cardiovasc Interv. 2016;9(12):e004782.CrossRefPubMedGoogle Scholar
  43. 43.
    Nerlekar NHF, Verma KP, Bennett MR, Cameron JD, Meredith IT, Brown AJ. Percutaneous coronary intervention using drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery stenosis a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2016;9(12):e004729.CrossRefPubMedGoogle Scholar
  44. 44.
    Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785–95.CrossRefPubMedGoogle Scholar
  45. 45.
    Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, et al. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (surgical treatment for ischemic heart failure). Circulation. 2016;134(18):1314–24.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–91.CrossRefPubMedGoogle Scholar
  47. 47.
    Shaw LJ, Weintraub WS, Maron DJ, Hartigan PM, Hachamovitch R, Min JK, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J. 2012;164(2):243–50.CrossRefPubMedGoogle Scholar
  48. 48.
    Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA, et al. A prospective natural history study of coronary atherosclerosis using fractional flow reserve. J Am Coll Cardiol. 2016;68(21):2247–55.CrossRefPubMedGoogle Scholar
  49. 49.
    Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–95.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Camici PG, d'Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol. 2015;12(1):48–62.CrossRefPubMedGoogle Scholar
  51. 51.
    Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38(33):2565–8.PubMedGoogle Scholar
  52. 52.
    Echavarria-Pinto M, van de Hoef TP, Serruys PW, Piek JJ, Escaned J. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation. Curr Opin Cardiol. 2014;29(6):564–70.CrossRefPubMedGoogle Scholar
  53. 53.
    Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054–60.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Lee JM, Jung JH, Hwang D, Park J, Fan Y, Na SH, et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol. 2016;67(10):1158–69.CrossRefPubMedGoogle Scholar
  55. 55.
    Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346(25):1948–53.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • David Corcoran
    • 1
    • 2
  • Damien Collison
    • 1
    • 2
  • Tom Ford
    • 1
    • 2
  • Colin Berry
    • 1
    • 2
    Email author
  1. 1.West of Scotland Heart and Lung Centre, Golden Jubilee National HospitalClydebankUK
  2. 2.British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of GlasgowGlasgowUK

Personalised recommendations